BioSpace News Archive

Job Trends

ForeverGreen Prepares to Launch its First of Many Products Featuring CBD Oil

First new product expected to launch in Q1 to be broad spectrum CBD hemp oil

February 4, 2019

·

2 min read

Policy

CHMP Recommends Approval of Praluent® (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the CHMP has adopted a positive opinion for Praluent® Injection

February 4, 2019

·

13 min read

Business

Macherey-Nagel GmbH & Co. KG and Andrew Alliance Sign Co-Marketing Agreement

Macherey-Nagel GmbH & Co. KG and Andrew Alliance announced they have signed an agreement stating that they are working together to develop an automated solution for the preparation of transfection grade plasmid DNA.

February 4, 2019

·

1 min read

Business

argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE® Technology

argenx gains access to ENHANZE® subcutaneous delivery technology for up to three targets, including exclusive rights to develop therapeutic products targeting human neonatal Fc receptor FcRn

February 4, 2019

·

8 min read

Drug Development

GenSight Biologics reports topline results at Week 48 of the RESCUE Phase III clinical trial of GS010 in subjects within six months of visual loss onset due to Leber Hereditary Optic Neuropathy (LHON)

Mean best-corrected visual acuity (BCVA) among GS010-treated eyes and sham-treated eyes evolved with similar trajectories, worsening to a low point, or nadir, before beginning to improve by Week 48 – coherent with REVERSE trial

February 4, 2019

·

13 min read

Business

QIAGEN Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project

QCI is a powerful, high quality decision support solution for rapid interpretation of hereditary diseases

February 4, 2019

·

1 min read

Dental Care for Dogs - It’s Not Just About Doggy Breath!

“Doggy breath” isn’t a nuisance that comes with the territory of choosing to have a canine companion.

February 4, 2019

·

1 min read

Pharm Country

Gore Range Announces Strategic Partnership Investment from LEO Pharma

Partnership melds firms’ commitment to innovation in dermatology and patient-centric approach

February 4, 2019

·

3 min read

BioForest

Syntrix Wins $3.4M NIH Grant to Conduct Phase 1/2 Trial of SX-682 in Myelodysplastic Syndrome

The phase 1/2 clinical trial will be carried out in collaboration with researchers at the Moffitt Cancer Center led by Dr. Rami Kamrokji.

February 4, 2019

·

2 min read

Pharm Country

Harmony Biosciences Certified As A Great Place To Work In An Independent Survey Of Workplace Cultures

Harmony Biosciences, LLC (Harmony), a private biopharmaceutical company dedicated to developing and commercializing novel treatment options for people living with rare diseases, announced today that the company was certified as a great workplace by independent analysts at Great Place to Work®.

February 4, 2019

·

2 min read